Anti-LMLN monoclonal antibody

Pre-made anti-LMLN monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to LMLN/LMLN products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1096-Ab-1/ GM-Tg-hg-IP1096-Ab-2Anti-Human LMLN monoclonal antibodyHuman
GM-Tg-rg-IP1096-Ab-1/ GM-Tg-rg-IP1096-Ab-2Anti-Rat LMLN monoclonal antibodyRat
GM-Tg-mg-IP1096-Ab-1/ GM-Tg-mg-IP1096-Ab-2Anti-Mouse LMLN monoclonal antibodyMouse
GM-Tg-cynog-IP1096-Ab-1/ GM-Tg-cynog-IP1096-Ab-2Anti-Cynomolgus/ Rhesus macaque LMLN monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1096-Ab-1/ GM-Tg-felg-IP1096-Ab-2Anti-Feline LMLN monoclonal antibodyFeline
GM-Tg-cang-IP1096-Ab-1/ GM-Tg-cang-IP1096-Ab-2Anti-Canine LMLN monoclonal antibodyCanine
GM-Tg-bovg-IP1096-Ab-1/ GM-Tg-bovg-IP1096-Ab-2Anti-Bovine LMLN monoclonal antibodyBovine
GM-Tg-equg-IP1096-Ab-1/ GM-Tg-equg-IP1096-Ab-2Anti-Equine LMLN monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1096-Ab-1/ GM-Tg-hg-IP1096-Ab-2; GM-Tg-rg-IP1096-Ab-1/ GM-Tg-rg-IP1096-Ab-2;
GM-Tg-mg-IP1096-Ab-1/ GM-Tg-mg-IP1096-Ab-2; GM-Tg-cynog-IP1096-Ab-1/ GM-Tg-cynog-IP1096-Ab-2;
GM-Tg-felg-IP1096-Ab-1/ GM-Tg-felg-IP1096-Ab-2; GM-Tg-cang-IP1096-Ab-1/ GM-Tg-cang-IP1096-Ab-2;
GM-Tg-bovg-IP1096-Ab-1/ GM-Tg-bovg-IP1096-Ab-2; GM-Tg-equg-IP1096-Ab-1/ GM-Tg-equg-IP1096-Ab-2
Products NameAnti-LMLN monoclonal antibody
Formatmab
Target NameLMLN
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-LMLN monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1096-Ag-1Recombinant multi-species LMLN/ GP63/ INV protein


    Target information

    Target IDGM-IP1096
    Target NameLMLN
    Gene ID89782,239833,363795,722196,609201,101096910,100337404,100070217
    Gene Symbol and Synonyms5330415H22Rik,GP63,INV,IX14,LMLN,LMNL1,MSP
    Uniprot AccessionQ96KR4
    Uniprot Entry NameLMLN_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000185621
    Target ClassificationN/A

    The target: LMLN, gene name: LMLN, also named as GP63, INV, IX14, LMNL1, MSP. This gene encodes a zinc-metallopeptidase. The encoded protein may play a role in cell migration and invasion. Studies of a similar protein in Drosophila indicate a potential role in mitotic progression. Alternatively spliced transcript variants have been described. [provided by RefSeq, Feb 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.